Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127426 trials found · Page 2434 of 6372
-
New combo pill aims to tackle high blood pressure
Disease control CompletedThis is an 8-week, randomized, double-blind Phase 3, multicentre study to determine the optimal dose of AZM and AML in combination therapy and to compare efficacy and tolerability of the combined therapy to each of the monotherapy in essential hypertensive subjects who are not ad…
Phase 3 • Sponsor: Celltrion • Aim: Disease control
Last updated Jun 26, 2026 15:52 UTC
-
New combo shot may beat standard insulin for diabetes control
Disease control CompletedThis was a parallel-group treatment, Phase 3, randomized, 2-arm study that assessed the efficacy and safety of iGlarLixi to IDegAsp in Chinese T2DM participants insufficiently controlled with oral antidiabetic drug(s). Study details included: * Study duration per participant: a…
Phase 3 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New brain scan study targets Alzheimer's in african american seniors
Knowledge-focused OngoingWe will conduct a Tau PET scan in cognitively normal older adults, enrolled in the Aging Brain Cohort Dedicated to Diversity Study (ABCD2-Tau) study at the University of Pennsylvania's Penn Memory Center/Alzheimer's Disease Core Center (PMC/ADC).Study duration will generally be a…
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
Needles vs. pills: can acupuncture cut opioid use after hip surgery?
Symptom relief CompletedAt this time, no formal ERAS (enhanced recovery after surgery) protocol exists for THR that incorporates perioperative acupuncture. Developing, and more importantly, validating a preliminary fast-track protocol for THR can have a significant impact on reducing recovery time and i…
Sponsor: Hospital for Special Surgery, New York • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Could a slower start to dialysis protect quality of life?
Disease control Recruiting nowThe INCH-HD trial will test if incremental HD preserves the quality of life of patients and families and is a safe, practical, cost effective treatment option.
Sponsor: The University of Queensland • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Talking it out: could CBT ease anxiety and depression in IBD patients?
Symptom relief CompletedThis is a prospective, single center, randomized treatment study to assess if anxiety and depression in participants with IBD can be improved with CBT compared to those treated with SKY.
Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Wrist access may be safer for carotid stenting in major new trial
Disease control CompletedBackground: For moderate to severe carotid artery atherosclerotic stenosis, in the past decades, carotid artery stenting (CAS) has been an alternative to carotid endarterectomy (CEA) for the treatment of carotid artery stenosis. The transfemoral artery (TFA) using Seldinger's tec…
Sponsor: The First Affiliated Hospital of University of Science and Technology of China • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Can acupuncture with electricity help seniors walk better?
Symptom relief Recruiting nowIntroduction: The efficacy of existing therapies for the treatment of sarcopenia is still not satisfactory. Therefore, this randomized controlled, assessor-blinded study was designed to investigate the efficacy and safety of electroacupuncture(EA) therapy in elderly patients with…
Sponsor: The Third Affiliated hospital of Zhejiang Chinese Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
Family support boosts PTSD treatment success in veterans
Symptom relief Recruiting nowAlthough effective treatments for PTSD exist, high rates of treatment dropout and sub-optimal response rates remain common. Incorporating family members in treatment represents one avenue for improving outcomes and providing Veteran-centered care, and surveys of Veterans in outpa…
Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
Tiny Aircraft-Inspired scope could revolutionize kidney stone removal
Disease control CompletedThe goal of this clinical trial is to introduce a novel multifunctional miniature endoscopic system, namely "Aircraft Nephroscope", for percutaneous nephrolithotomy (PCNL) to treat the patients with urolithiasis. The main questions it aims to answer are: 1. Is the "Aircraft Neph…
Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Personalized medicine hope: genetic screening for pancreatic cancer
Knowledge-focused Recruiting nowThe proposal is to implement a molecular screening program for advanced/metastatic pancreatic cancer patients before the initiation of 1st line treatment in order to allow a better selection of patients for rationale personalized medicine with targeted agents and/or combination i…
Sponsor: Centre Leon Berard • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Could flickering lights and tones boost brain function in Alzheimer's?
Symptom relief OngoingThe purpose of the study is to investigate the efficacy of cortical gamma oscillation on visual sensory processing and cognitive function in Alzheimer's Disease (AD) patients by combining a therapeutic sensory stimulation device capable of evoking 40-Hz gamma oscillation via non-…
Sponsor: University of Tennessee Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Smartphone app could let diabetic foot ulcer patients skip clinic visits for wound checks
Disease control CompletedThe feasibility phase of the study was conducted to assess the feasibility of a novel, patient-centered, remote wound management system. The investigators will enroll 25 patients with an active diabetic foot ulcer (DFU) who present to the multidisciplinary diabetic foot clinic in…
Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Can nexium keep Kids' esophagitis at bay? new study seeks answers
Disease control OngoingThe aim of the study is to compare the safety and efficacy of two doses of Nexium in maintaining healing of erosive esophagitis in patients 1 to 11 years of age.
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Could a headset at home ease ADHD symptoms?
Symptom relief Recruiting nowThe investigators are investigating whether home-based tDCS over the course of four weeks can improve ADHD symptom severity and improve dysexecutive functioning (cognitive control). Further, the investigators are investigating whether there is a dose-dependent response to tDCS.
Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Dissolving stent could spare kidney stone patients a second procedure
Disease control Recruiting nowA prospective, multi-center, non-randomized trial to demonstrate safety and device performance of the ADVA-Tec Uriprene® Degradable Temporary Ureteral Stent.
Sponsor: Adva-Tec • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Could your sex change how Alzheimer's shows up in your blood?
Knowledge-focused OngoingBlood-based ADRD biomarkers show tremendous promise as a non-invasive method to predict and diagnose ADRD. We will measure changes in these biomarkers to determine whether their ability to predict ADRD differs by sex or by other characteristics, and develop a sex-specific ADRD ri…
Sponsor: Anne Murray • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
New hope for ulcerative colitis: drug shows promise in early trial
Disease control CompletedTo evaluate the efficacy of IBI112 induction therapy in patients with moderate and severe active Ulcerative Colitis (UC) to achieve clinical remission.
Phase 2 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Spirulina extract shows promise in strengthening immune defenses against viruses
Disease control CompletedThis randomized, double blind, placebo controlled study aims to establish the impact of the oral supplement, Immulina TM, on enhancing host resilience to the effects of viral influenza infection in humans.
Phase 3 • Sponsor: University of Mississippi Medical Center • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
One-month TB pill regimen tested for kidney transplant hopefuls
Disease control OngoingThis is a prospective, single-center, single-arm, open-label study investigating the safety, compliance and pharmacokinetics of 1-month treatment of Isoniazid, Rifapentine and Vitamin B6 in renal transplant candidates.
Phase 4 • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC